---
$id: https://graph.org.ai/products/commodity/51241107
$type: Product
source: UNSPSC
code: "51241107"
title: "Dorzolamide"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dorzolamide

**UNSPSC Code**: 51241107
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a carbonic anhydrase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9JDX055TW1. European Medicines Agency schedules Dorzolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06374MIG. Dorzolamide generally arises in the molecular formula C10H16N2O4S3. The term DORZOLAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33.) DORZOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dorzolamide under HS 29350090 and SITC 51580. As of Q4 2014, DORZOLAMIDE remains the US FDA Preferred Term for this commodity. Dorzolamide bears US NLM identifiers UMLS ID C0165590 and NCI Concept Code C62026. SMILES: CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.

